Chordate Medical (Sweden) Insiders
| CMH Stock | 12.55 0.25 1.95% |
Chordate Medical employs about 3 people. The company is managed by 5 executives with a total tenure of roughly 7 years, averaging almost 1.0 years of service per executive, having 0.6 employees per reported executive. Breaking down Chordate Medical's management performance can provide insight into the firm performance.
| Jan Hermansson Insider Head Director |
| Anders Weilandt Insider CEO MD |
Chordate |
Chordate Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.7129) % which means that it has lost $0.7129 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6754) %, meaning that it generated substantial loss on money invested by shareholders. Chordate Medical's management efficiency ratios could be used to measure how well Chordate Medical manages its routine affairs as well as how well it operates its assets and liabilities.Chordate Medical Workforce Comparison
Chordate Medical Holding is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 21,275. Chordate Medical adds roughly 3.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.
Chordate Medical Holding Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Chordate Medical Holding Price Series Summation is a cross summation of Chordate Medical price series and its benchmark/peer.
Chordate Medical Notable Stakeholders
A Chordate Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chordate Medical often face trade-offs trying to please all of them. Chordate Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chordate Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jan Hermansson | Head Director | Profile | |
| Anders Weilandt | CEO MD | Profile | |
| Jan Lindberg | CTO Mang | Profile | |
| Niklas Lindecrantz | Chief Officer | Profile | |
| Helena Thedius | Sales Mang | Profile |
About Chordate Medical Management Performance
The success or failure of an entity such as Chordate Medical Holding often depends on how effective the management is. Chordate Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chordate management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chordate management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Chordate Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chordate Medical Holding. Check Chordate Medical's Beneish M Score to see the likelihood of Chordate Medical's management manipulating its earnings.
Chordate Medical Workforce Analysis
Traditionally, organizations such as Chordate Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chordate Medical within its industry.Chordate Medical Manpower Efficiency
Return on Chordate Medical Manpower
| Revenue Per Employee | 206K | |
| Revenue Per Executive | 123.6K | |
| Net Loss Per Employee | 6.6M | |
| Net Loss Per Executive | 4M |
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.